Schizophrenia & Psychosis at AAAP 37th Annual Meeting and Scientific Symposium

12 sessions on schizophrenia & psychosis · November 12–15, 2026, Memphis, TN. Compare schizophrenia & psychosis at other meetings →

Friday, November 13

15:30–17:00 · Oral abstract
Short-Term Clinical Outcomes in Early Psychosis with and without Recent Substance Use: The Role of Urine Drug Screening and Antipsychotics in an Urban Youth Cohort
Chaden Noureddine
Looks at short-term outcomes in youth with early psychosis by recent substance use, urine drug screening and antipsychotic use.
Child & Adolescent · Substance Use Disorders

Cannabis Use and Psychosis: A Case Series Highlighting Risk Factors for Schizophrenia-Spectrum Disorders. — Emily Waller
Association between Cannabis-Related Disorders and Incident Psychosis in Individuals with Adhd — Christian Nolan
Childhood Trauma and Motives for Cannabis Use in Individuals with Psychosis — Yousef Khan
High-Potency Cannabis as a Modifiable Risk Factor for Cannabis-Induced Psychosis in Adolescents and Young Adults — Sophia Azmi
Single-Dose 7-Hydroxymitragynine Induced Psychosis and Delirium Requiring Intensive Care — Jovesh Zachariah
Substance Use Burden and Psychiatric Readmission following Long-Acting Injectable Antipsychotic Initiation — Angelo Chaia
Recurrent Cannabis Withdrawal-Associated Psychosis: A Case Report — Itamar Shapira
Substance Use Patterns and Clinical Complexity as Predictors of Psychiatric Readmission among Inpatients Receiving Long-Acting Injectable Antipsychotics — Kathryn Renard
Successful Treatment of a Patient with Severe 7-OH Abuse and Chronic Psychosis. — Jenna Dolan
Acute Psychosis and Opioid Withdrawal Associated with 7-Hydroxymitragynine Use: A Case Report — Nicole Lord
Psychosis or Encephalopathy? Addiction Psychiatry Challenges in Co-Occurring Schizophrenia, Alcohol Use Disorder, and Decompensated Liver Disease — Fnu Shashi Kant